Thirty years of active surveillance for low-risk thyroid cancer, lessons learned and future directions
- 14 October 2023
- journal article
- review article
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 25 (1) , 65-78
Abstract
Active Surveillance is a non-invasive strategy designed to identify a minority of patients with low-risk papillary thyroid carcinoma who might experience clinical progression and benefit from additional definitive treatments. Global experience suggests that these tumors typically show minimal changes in size during active surveillance, often demonstrating very slow growth or even size reduction. Moreover, the rate of lymph node metastases is low and can be effectively managed through rescue surgery, without impacting cancer-related mortality. However, despite 30 years of experience demonstrating the safety and feasibility of active surveillance for appropriately selected patients, this approach seems to have limited adoption in specific contexts. This limitation can be attributed to various barriers, including disparities in access to accurate information about the indolent nature of this disease and the prevalence of a maximalist mindset among certain patients and medical settings. This review aims to revisit the experience from the last three decades, provide current insights into the clinical outcomes of active surveillance trials, and propose a systematic approach for its implementation. Furthermore, it intends to emphasize the importance of precise patient selection and provides new perspectives in the field.Keywords
This publication has 72 references indexed in Scilit:
- Annual financial impact of well‐differentiated thyroid cancer care in the United StatesCancer, 2014
- Extent of Thyroidectomy and Incidence of Morbidity2012
- A Large Multicenter Correlation Study of Thyroid Nodule Cytopathology and HistopathologyThyroid®, 2011
- Three Distinctly Different Kinds of Papillary Thyroid Microcarcinoma should be Recognized: Our Treatment Strategies and OutcomesWorld Journal of Surgery, 2010
- Presurgical Serum Thyroglobulin Has No Prognostic Value in Papillary Thyroid CancerThyroid®, 2005
- Epidemiology of Thyroid Microcarcinoma Found in Autopsy Series Conducted in Areas of Different Iodine IntakeThyroid®, 2005
- Complications of Thyroid Surgery: Analysis of a Multicentric Study on 14,934 Patients Operated on in Italy over 5 YearsWorld Journal of Surgery, 2004
- An Observation Trial Without Surgical Treatment in Patients with Papillary Microcarcinoma of the ThyroidThyroid®, 2003
- Lymph Node Metastasis From 259 Papillary Thyroid MicrocarcinomasAnnals of Surgery, 2003
- Regulation of Thyroid Cell Proliferation by TSH and Other Factors: A Critical Evaluation of in Vitro ModelsEndocrine Reviews, 2001